Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 25Neoplasm Metastasis 15Neoplasms 13Rectal Neoplasms 8Colorectal Cancer Metastatic 7Colonic Neoplasms 6Ovarian Neoplasms 5Lymphoma, Non-Hodgkin 5Uveal Melanoma 4Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Melanoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Burkitt Lymphoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Urethral Neoplasms 3Stomach Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Glioblastoma 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3

Interventions

Quality of Life 2Nutritional Status 2Interviews as Topic 2sintilimab 1danvatirsen 1contrast agent BR1 1catumaxomab 1aflibercept 1Zoledronic Acid 1Vascular Access Devices 1Portasystemic Shunt, Transjugular Intrahepatic 1Octreotide 1Hyperthermic Intraperitoneal Chemotherapy 1Catheters, Indwelling 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ascites × aflibercept × Clear all
NCT00327444 2013-01-01

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Sanofi

Phase 2/3 Completed
58 enrolled 11 charts
Gynecologic

Ascites, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡